Chairman
Peter L. Rosenbaum, MD
Professor of Paediatrics
CanChild Centre for Childhood Disability Research
McMaster University
Hamilton, ON
CPIRF Medical Director
James A. Blackman, MD, MPH
Professor of Pediatrics Emeritus,
University of Virginia
Princeton Junction, NJ
William W. Andrews, MD
Chairman and Professor
Department of Obstetrics and Gynecology
University of Alabama at Birmingham
Birmingham, AL
Hank Chambers, MD
Rady Children’s Hospital & Health Center
Children’s Specialists Orthopedic Center
San Diego, CA
Ted Conway, PhD
Program Director
General & Age Related Disabilities Engineering (GARDE)
Division of Chemical, Bioengineering, Environmental & Transport Systems
Engineering Directorate
National Science Foundation
Arlington, VA
Diane Damiano, PT, PhD
Chief of Functional & Applied Biomechanics Section
National Institutes of Health
Bethesda, MD
David H. Rowitch, MD, PhD
Professor of Pediatrics and Neurosurgery Chief of Neonatology
Investigator,
Howard Hughes Institute
UCSF
Children’s Hospital
San Francisco, CA
Marshalyn Yeargin-Allsopp, MD
Chief, Developmental Disabilities Branch
National Center for Birth Defects and Developmental Disabilities
Centers for Disease Control and Prevention
Atlanta, GA
Special Advisor/former SAC Chair
Murray Goldstein, DO, MPH
Bethesda, MD
Most treatments for cerebral palsy (CP) are initially directed toward children. What is not clearly established is the long- term effects of such treatments. Many appear helpful in the short term but prove to be disadvantageous in the long run. Selective dorsal rhizotomy (SDR) is a permanent, irreversible neurosurgical procedure for reducing spasticity in cerebral palsy. Parents contemplating SDR for their child would like assurance that that there will not be harmful complications from it as the child ages into adolescence and adulthood. We now have new evidence...
